ERS 2016

September 21, 2016September 21, 2016

New Data Supports Esbriet as Safe, Effective Treatment for IPF Patients

Positive results from four analyses based on clinical trials developed by Roche to evaluate the effectiveness of Esbriet (pirfenidone), an oral antifibrotic medication approved by the U.S. Food and Drug ... Read more

September 19, 2016September 19, 2016

Spiriva Respimat Safely Improves Lung Function in Kids with Asthma, New Study Results Show

Asthma, News

Boehringer Ingelheim recently announced new results showing that Spiriva Respimat (tiotropium bromide) improved lung function in asthmatic children ages 6 to 11. Data also suggested the drug is safe in children ages 6 ... Read more

September 15, 2016September 15, 2016

Homogeneous Emphysema Patients Could Benefit from Zephyr Endobronchial Valve, Study Shows

Emphysema, News

Pulmonx recently announced positive results from the IMPACT (NCT02025205) study assessing the company’s proprietary Zephyr endobronchial valve (EBV), showing that patients with homogeneous emphysema benefit from the treatment. The Zephyr EBV is ... Read more

September 14, 2016September 14, 2016

Boehringer Reports Long-term Positive Effects of IPF Therapy Ofev

Idiopathic Pulmonary Fibrosis, News

Boehringer Ingelheim recently shared positive data from a clinical trial evaluating long-term treatment with Ofev (nintedanib) in idiopathic pulmonary fibrosis (IPF) patients. The interim findings from the INPULSIS-ON extension trial were ... Read more

September 6, 2016September 6, 2016

Philips Sponsoring Film on Leonard Nimoy and His Final Struggle with COPD

COPD, News

Royal Philips is sponsoring a new documentary, “COPD: Highly Illogical – Remembering Leonard Nimoy,“ which provides an intimate look at the actor’s life, legacy, and his final years confronting chronic obstructive pulmonary disease ... Read more